214 related articles for article (PubMed ID: 7803702)
21. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.
McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB
Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742
[TBL] [Abstract][Full Text] [Related]
22. Molecular and genetic analysis of liver oncogenesis in transforming growth factor alpha transgenic mice.
Takagi H; Sharp R; Hammermeister C; Goodrow T; Bradley MO; Fausto N; Merlino G
Cancer Res; 1992 Oct; 52(19):5171-7. PubMed ID: 1394122
[TBL] [Abstract][Full Text] [Related]
23. Serum insulin-like growth factor-I and mammary tumor development in ad libitum-fed, chronic calorie-restricted, and intermittent calorie-restricted MMTV-TGF-alpha mice.
Rogozina OP; Bonorden MJ; Grande JP; Cleary MP
Cancer Prev Res (Phila); 2009 Aug; 2(8):712-9. PubMed ID: 19654106
[TBL] [Abstract][Full Text] [Related]
24. Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation.
Gorska AE; Jensen RA; Shyr Y; Aakre ME; Bhowmick NA; Moses HL
Am J Pathol; 2003 Oct; 163(4):1539-49. PubMed ID: 14507660
[TBL] [Abstract][Full Text] [Related]
25. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene.
Böttinger EP; Jakubczak JL; Haines DC; Bagnall K; Wakefield LM
Cancer Res; 1997 Dec; 57(24):5564-70. PubMed ID: 9407968
[TBL] [Abstract][Full Text] [Related]
26. Ectopic vasopressin expression in MMTV-Wnt-1 transgenic mice modifies mammary tumor differentiation and pathology.
Chooi KF; Carter DA; Biswas S; Lightman SL; Ho MY; Murphy D
Cancer Res; 1994 Dec; 54(24):6434-40. PubMed ID: 7987839
[TBL] [Abstract][Full Text] [Related]
27. Nonuniform expression of a mouse mammary tumor virus-driven int-2/Fgf-3 transgene in pregnancy-responsive breast tumors.
Stamp G; Fantl V; Poulsom R; Jamieson S; Smith R; Peters G; Dickson C
Cell Growth Differ; 1992 Dec; 3(12):929-38. PubMed ID: 1335281
[TBL] [Abstract][Full Text] [Related]
28. Activation of phosphatidylinositol 3-kinase by membrane localization of p110alpha predisposes mammary glands to neoplastic transformation.
Renner O; Blanco-Aparicio C; Grassow M; Cañamero M; Leal JF; Carnero A
Cancer Res; 2008 Dec; 68(23):9643-53. PubMed ID: 19047141
[TBL] [Abstract][Full Text] [Related]
29. Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice.
Matsui Y; Halter SA; Holt JT; Hogan BL; Coffey RJ
Cell; 1990 Jun; 61(6):1147-55. PubMed ID: 2161707
[TBL] [Abstract][Full Text] [Related]
30. Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis: coordinated stimulation of growth and suppression of apoptosis.
Amundadottir LT; Nass SJ; Berchem GJ; Johnson MD; Dickson RB
Oncogene; 1996 Aug; 13(4):757-65. PubMed ID: 8761297
[TBL] [Abstract][Full Text] [Related]
31. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice.
Krane IM; Leder P
Oncogene; 1996 Apr; 12(8):1781-8. PubMed ID: 8622899
[TBL] [Abstract][Full Text] [Related]
32. Understanding mammary gland development through the imbalanced expression of growth regulators.
Robinson GW; Smith GH; Gallahan D; Zimmer A; Furth PA; Hennighausen L
Dev Dyn; 1996 Jun; 206(2):159-68. PubMed ID: 8725283
[TBL] [Abstract][Full Text] [Related]
33. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
Blavier L; Lazaryev A; Dorey F; Shackleford GM; DeClerck YA
Cancer Res; 2006 Mar; 66(5):2691-9. PubMed ID: 16510589
[TBL] [Abstract][Full Text] [Related]
34. Reducing mammary cancer risk through premature stem cell senescence.
Boulanger CA; Smith GH
Oncogene; 2001 Apr; 20(18):2264-72. PubMed ID: 11402321
[TBL] [Abstract][Full Text] [Related]
35. Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth.
Vomachka AJ; Pratt SL; Lockefeer JA; Horseman ND
Oncogene; 2000 Feb; 19(8):1077-84. PubMed ID: 10713693
[TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor alpha and mouse models of human breast cancer.
Humphreys RC; Hennighausen L
Oncogene; 2000 Feb; 19(8):1085-91. PubMed ID: 10713694
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice.
Ha HY; Moon HB; Nam MS; Lee JW; Ryoo ZY; Lee TH; Lee KK; So BJ; Sato H; Seiki M; Yu DY
Cancer Res; 2001 Feb; 61(3):984-90. PubMed ID: 11221894
[TBL] [Abstract][Full Text] [Related]
38. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene.
Robinson GW; Wagner KU; Hennighausen L
Oncogene; 2001 Oct; 20(48):7115-9. PubMed ID: 11704837
[TBL] [Abstract][Full Text] [Related]
39. GFP expression in the mammary gland for imaging of mammary tumor cells in transgenic mice.
Ahmed F; Wyckoff J; Lin EY; Wang W; Wang Y; Hennighausen L; Miyazaki J; Jones J; Pollard JW; Condeelis JS; Segall JE
Cancer Res; 2002 Dec; 62(24):7166-9. PubMed ID: 12499251
[TBL] [Abstract][Full Text] [Related]
40. Cause of failure of lactation in mouse mammary tumor virus/human transforming growth factor alpha transgenic mice.
Sakai S; Mizuno M; Harigaya T; Yamamoto K; Mori T; Coffey RJ; Nagasawa H
Proc Soc Exp Biol Med; 1994 Mar; 205(3):236-42. PubMed ID: 8171044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
